VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PRLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PRLBProto Labs, Inc.
$80.69$1.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPRLBFinancials

Proto Labs, Inc. (PRLB) Financials

17Y historyFree accessUpdated daily

Revenue growth has rebounded to 10.4% in 2026Q1, though operating margins remain constrained in the low-to-mid single digits due to elevated SG&A and R&D spending.

PRLB Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Sales/Revenue546.26M533.13M500.89M503.88M488.4M488.1M434.39M458.73M445.6M344.49M298.06M264.11M209.58M163.11M125.99M98.94M64.92M43.83M
Revenue Growth %9.43%6.44%-0.59%3.17%0.06%12.36%-5.3%2.95%29.35%15.58%12.85%26.02%28.49%29.46%27.34%52.4%48.11%-
Cost of Goods Sold301.23M295.99M277.69M281.88M272.93M265.41M216.57M223.44M206.92M150.65M131.12M109.7M81.18M61.41M49.85M39.32M25.44M18.56M
COGS % of Revenue-55.52%55.44%55.94%55.88%54.38%49.86%48.71%46.44%43.73%43.99%41.54%38.73%37.65%39.57%39.75%39.19%42.34%
Gross Profit245.03M237.14M223.2M221.99M215.47M222.69M217.83M235.29M238.68M193.84M166.94M154.4M128.4M101.7M76.14M59.62M39.48M25.27M
Gross Margin %44.86%44.48%44.56%44.06%44.12%45.62%50.14%51.29%53.56%56.27%56.01%58.46%61.27%62.35%60.43%60.25%60.81%57.66%
Gross Profit Growth %-6.24%0.54%3.03%-3.24%2.23%-7.42%-1.42%23.13%16.12%8.12%20.25%26.25%33.58%27.72%51.02%56.19%-
Operating Expenses213.48M210.94M197.7M193.61M188.52M194.85M157.99M155.43M149.78M121.62M105.17M87.05M67.37M50.4M41.19M32.75M22.78M17.37M
OpEx % of Revenue-39.57%39.47%38.42%38.6%39.92%36.37%33.88%33.61%35.3%35.29%32.96%32.15%30.9%32.69%33.1%35.09%39.62%
Selling, General & Admin169.32M168.13M156.41M153.48M150.3M150.61M121.05M122.74M121.05M98.06M82.78M68.7M50.77M38.54M32.05M27.52M18.5M14.23M
SG&A % of Revenue-31.54%31.23%30.46%30.77%30.86%27.87%26.76%27.16%28.46%27.77%26.01%24.22%23.63%25.44%27.82%28.49%32.46%
Research & Development42.74M42.81M41.3M40.13M38.22M44.24M36.94M32.69M28.73M23.56M22.39M18.35M16.61M11.86M9.14M5.22M4.28M3.14M
R&D % of Revenue-8.03%8.24%7.97%7.83%9.06%8.5%7.13%6.45%6.84%7.51%6.95%7.92%7.27%7.25%5.28%6.59%7.16%
Other Operating Expenses1000K00000000000000000
Operating Income31.55M26.2M25.5M28.38M26.95M27.84M59.84M79.86M88.9M72.23M61.77M67.15M60.53M51.3M34.95M26.87M16.7M7.91M
Operating Margin %5.78%4.91%5.09%5.63%5.52%5.7%13.77%17.41%19.95%20.97%20.72%25.42%28.88%31.45%27.74%27.16%25.72%18.04%
Operating Income Growth %-2.77%-10.17%5.33%-3.2%-53.47%-25.07%-10.17%23.08%16.93%-8.02%10.94%17.99%46.8%30.06%60.9%111.19%-
EBITDA56.67M60.02M61.3M65.91M66.37M68.33M92.43M110.72M115.65M90.7M79.25M81.28M71.67M58.87M41.03M31.13M20.18M10.81M
EBITDA Margin %10.37%11.26%12.24%13.08%13.59%14%21.28%24.14%25.95%26.33%26.59%30.77%34.19%36.09%32.56%31.47%31.09%24.67%
EBITDA Growth %-3.23%-2.1%-6.99%-0.7%-2.86%-26.08%-16.52%-4.26%27.51%14.45%-2.49%13.41%21.74%43.49%31.78%54.26%86.63%-
D&A (Non-Cash Add-back)25.12M33.81M35.81M37.53M39.42M40.49M32.59M30.86M26.75M18.47M17.48M14.13M11.14M7.57M6.08M4.26M3.48M2.91M
EBIT25.08M31.06M24.87M29.05M-97.88M40.18M62.95M81.19M91.66M74.44M64.22M67.86M60.53M51.58M34.97M26.75M15.71M7.39M
Net Interest Income2.35M05.2M2.2M1M200K1.4M2.1M1.7M000000000
Interest Income2.35M05.4M3.3M1M200K1.4M2.1M1.7M000000000
Interest Expense00200K1.1M00000000000000
Other Income/Expense4.85M4.86M-824K-430K-124.82M12.35M3.11M1.34M2.76M2.21M2.45M712K3K279K23K-114K-986K-517K
Pretax Income36.39M31.06M24.67M27.95M-97.88M40.18M62.95M81.19M91.66M74.44M64.22M67.86M60.53M51.58M34.97M26.75M15.71M7.39M
Pretax Margin %6.66%5.83%4.93%5.55%-20.04%8.23%14.49%17.7%20.57%21.61%21.55%25.69%28.88%31.62%27.76%27.04%24.2%16.86%
Income Tax10.64M9.82M8.08M10.73M5.58M6.81M12.08M17.54M15.07M22.66M21.51M21.35M18.9M16.3M10.94M8.78M4.76M3.17M
Effective Tax Rate %29.24%31.62%32.75%38.39%-5.71%16.95%19.19%21.6%16.44%30.44%33.5%31.46%31.22%31.6%31.3%32.83%30.31%42.86%
Net Income25.75M21.24M16.59M17.22M-103.46M33.37M50.87M63.66M76.59M51.78M42.71M46.51M41.63M35.28M24.02M17.97M10.95M4.22M
Net Margin %4.71%3.98%3.31%3.42%-21.18%6.84%11.71%13.88%17.19%15.03%14.33%17.61%19.87%21.63%19.07%18.16%16.87%9.63%
Net Income Growth %72.56%28.01%-3.64%116.64%-410.03%-34.39%-20.09%-16.89%47.92%21.24%-8.18%11.72%18.02%46.83%33.68%64.11%159.32%-
Net Income (Continuing)25.75M21.24M16.59M17.22M-103.46M33.37M50.87M63.66M76.59M51.78M42.71M46.51M41.63M35.28M24.02M17.97M10.95M4.22M
Discontinued Operations000000000000000000
Minority Interest000000000000000000
EPS (Diluted)1.060.880.660.66-3.771.211.892.352.811.931.611.771.601.360.981.360.220.00
EPS Growth %75.64%33.33%0%117.51%-411.57%-35.98%-19.57%-16.37%45.6%19.88%-9.04%10.63%17.65%38.78%-27.94%518.18%--
EPS (Basic)-0.890.660.66-3.771.211.902.372.841.941.621.791.621.401.031.390.240.00
Diluted Shares Outstanding24.29M24.25M25.21M26.22M27.41M27.65M26.9M27.05M27.28M26.85M26.56M26.32M26.1M25.86M24.44M13.23M19.93M19.93M
Basic Shares Outstanding23.84M23.92M25.1M26.19M27.41M27.62M26.74M26.87M26.98M26.65M26.37M26.01M25.69M25.2M23.37M12.9M18.34M18.34M
Dividend Payout Ratio------------------

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowImproving
Top Statement Risk

Cyclical R&D spending sensitivity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Rebounds From Trough

According to the latest quarterly financial data, Proto Labs achieved a 10.4% year-over-year revenue increase in 2026Q1, marking a significant recovery from the negative growth territory observed throughout 2024 and early 2025, suggesting that the company's pivot toward on-demand production is finally gaining meaningful commercial traction.

The return to double-digit growth indicates that the company may be successfully navigating the transition from a pure prototyping shop to a broader manufacturing partner. Investors should monitor whether this acceleration is driven by higher volume from existing customers or successful penetration into new industrial verticals.

Gross Margin Stability Amid Scale

As reported in recent income statements, Proto Labs has maintained a consistent gross margin profile hovering near 44% to 45%, demonstrating that the company's automated quoting and manufacturing infrastructure effectively absorbs fluctuations in input costs while preserving the premium pricing power inherent in its digital manufacturing model.

The stability of these margins suggests that the company's proprietary computational geometry engine remains a formidable moat against commoditization. However, the lack of significant margin expansion despite revenue growth implies that the cost of maintaining this digital infrastructure remains a persistent drag on potential profitability.

Operating Leverage Remains Constrained

Based on the provided financial figures, operating margins have struggled to scale proportionally with revenue, remaining in the low-to-mid single digits, which indicates that the company's heavy investment in SG&A and R&D continues to offset the efficiency gains realized through its automated manufacturing and quoting platform.

The persistent gap between gross and operating margins suggests that the company is still in a phase of heavy reinvestment to support its platform-based business model. This warrants further investigation into whether the current SG&A structure is a permanent requirement for growth or if it represents an inefficiency that could be optimized.

Earnings Quality Impacted By SBC

Analysis of the income statement reveals that stock-based compensation remains a recurring and material expense, frequently exceeding $3 million per quarter, which creates a notable divergence between GAAP net income and the underlying operational cash generation capacity of the business as reported in recent filings.

The reliance on equity-based incentives to attract software talent appears to be a structural feature of the company's cost base. Investors should be cautious of the dilutive impact of these grants, as they consistently dampen the earnings per share growth that would otherwise be more pronounced during periods of revenue expansion.

Competitive Risks To Margin Sustainability

While the company maintains a strong competitive position, the recent stagnation in core factory revenue growth suggests that the high-speed prototyping market may be facing increased pressure from localized, lower-cost digital competitors, potentially threatening the long-term sustainability of the company's current 44% gross margin profile.

Short-term revenue gains may mask a deeper risk where the 'speed premium' is being eroded by the commoditization of automated quoting tools. If competitors can replicate the Proto Labs experience at a lower price point, the company may be forced to choose between sacrificing volume or further compressing its already thin operating margins.

PRLB — Frequently Asked Questions

Quick answers to the most common questions about buying PRLB stock.

What was Proto Labs, Inc.'s (PRLB) revenue in 2025?

For fiscal year 2025, Proto Labs, Inc. (PRLB) reported total revenue of $533.1M. This represents a 1116.3% increase compared to $43.8M in 2009.

Is Proto Labs, Inc. (PRLB) profitable?

Proto Labs, Inc. (PRLB) is profitable, generating $21.2M in net income for the fiscal year ending 2025 with a net profit margin of 4.0%.

What is Proto Labs, Inc.'s operating profit margin?

Proto Labs, Inc. (PRLB) reported an operating income of $26.2M, resulting in an operating profit margin of 4.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Proto Labs, Inc.'s gross profit and gross margin?

Proto Labs, Inc. (PRLB) generated $237.1M in gross profit for the year, representing a gross profit margin of 44.5%. This demonstrates the company's core pricing power and production efficiency.